Study Name: A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
23 locations found
- Study Name Unavailable
Location: Birmingham, Alabama 35233
- Study Name Unavailable
Location: Chandler, Arizona 85224
- Study Name Unavailable
Location: Hot Springs, Arkansas 71913
- Study Name Unavailable
Location: Bakersfield, California 93309
- Study Name Unavailable
Location: Burbank, California 91505
- Study Name Unavailable
Location: Denver, Colorado 80220
- Study Name Unavailable
Location: Norwalk, Connecticut 06856
- Study Name Unavailable
Location: Washington, District of Columbia 20007
- Study Name Unavailable
Location: Miami, Florida 33143
- Study Name Unavailable
Location: Atlanta, Georgia 30342
- Study Name Unavailable
Location: Marietta, Georgia 30060
- Study Name Unavailable
Location: Wichita, Kansas 67214
- Study Name Unavailable
Location: Marrero, Louisiana 70072
- Study Name Unavailable
Location: Baltimore, Maryland 21237
- Study Name Unavailable
Location: Bethesda, Maryland 20817
- Study Name Unavailable
Location: St. Louis, Missouri 63110
- Study Name Unavailable
Location: Morristown, New Jersey 07960
- Study Name Unavailable
Location: Voorhees, New Jersey 08043
- Study Name Unavailable
Location: Lake Success, New York 11042
- Study Name Unavailable
Location: Philadelphia, Pennsylvania 19106
- Study Name Unavailable
Location: Pittsburgh, Pennsylvania 15232
- Study Name Unavailable
Location: Houston, Texas 77030
- Study Name Unavailable
Location: Temple, Texas 76508
|